IL-6 is commonly produced by a variety of cancer types including breast, lung, liver, and prostate cancer and elevated serum IL-6 is generally correlated with poor outcomes in cancer patients [134,135,136,137]. The gene discussed is IL6; the disease is Familial prostate cancer.